XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.25.1

Investments | 3 Months Ended
--- | ---
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract] |
Investments | 3. Investments Investments consist of the following (in thousands):
| March 31, 2025 |  | December 31, 2024
Equity method - performance allocations | $ | 6,195,873 |  |  | $ | 5,958,079 |
Equity method - capital interests (includes assets pledged of $657,356 and $647,448 as of March 31, 2025 and December 31, 2024, respectively) | 1,369,749 |  |  | 1,284,255 |
Loan held for sale | 65,591 |  |  | 47,880 |
Investments held to maturity, at amortized cost (includes assets pledged of $76,485 and $73,485 as of March 31, 2025 and December 31, 2024, respectively) | 82,390 |  |  | 78,941 |
Investments held for sale and other(a) | 179,263 |  |  | 121,995 |
Equity method - other | 13,083 |  |  | 12,003 |
Equity investments | 139 |  |  | 128 |
Total investments | $ | 7,906,088 |  |  | $ | 7,503,281 |
_______________ (a)As of March 31, 2025 and December 31, 2024, investments held for sale and other includes $81.3 million and $78.1 million, respectively, of investments held for sale for which the fair value option has been elected. Net gains (losses) from performance allocations and capital interests are disclosed in the Revenue section of Note 2 to the Condensed Consolidated Financial Statements. The following table summarizes net gains (losses) from investment activities (in thousands):
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Net losses of investments held for sale and other | $ | (2,572) |  |  | $ | — |  |  |  |  |
Net losses of equity method investments, fair value option | — |  |  | (5,484) |  |  |  |  |
Net gains (losses) of equity method investments - other | 474 |  |  | (116) |  |  |  |  |
Net gains from equity investments | 11 |  |  | 402 |  |  |  |  |
Total net losses from investment activities | $ | (2,087) |  |  | $ | (5,198) |  |  |  |  |
Loan Held for Sale As of March 31, 2025 and December 31, 2024, the Company entered into a short-term funding arrangement as part of the Company’s capital markets activities for $65.6 million and $47.9 million, respectively, which is recorded at amortized cost basis in investments on the Condensed Consolidated Statements of Financial Condition. Investments Held to Maturity, at Amortized Cost In connection with the acquisition of TPG Angelo Gordon, the Company acquired investments held to maturity, and the carrying value of these investments are included in investments on the Condensed Consolidated Statements of Financial Condition. The Company estimates an allowance for credit losses (“ACL”) on the investments classified as held to maturity securities. The fair value of investments held to maturity, excluding any reserves for credit losses, was $84.1 million and $81.6 million at March 31, 2025 and December 31, 2024, respectively. Equity Method Investments The Company evaluates its equity method investments in which it has not elected the fair value option for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable. During the three months ended March 31, 2025 and 2024, the Company did not recognize any impairment losses on an equity method investment without a readily determinable fair value.

X
- Definition Disclosure Of Equity Method Investments And Equity Securities, FV-NI + References No definition available. + Details
Name: | tpg_DisclosureOfEquityMethodInvestmentsAndEquitySecuritiesFVNITextBlock
Namespace Prefix: | tpg_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration